A Case of atypical Femoral Fracture after Dosing Denosumab

For the management of patients with castration-resistant prostate cancer with bone metastases, bisphosphonates and denosumab are used to prevent skeletal related events. Osteonecrosis of the jaw and hypocalcemia have been reported in patients treated with denosumab, but there have been few reports o...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 66(2020), 1 vom: 03. Jan., Seite 23-27
Auteur principal: Takahashi, Toshifumi (Auteur)
Autres auteurs: Ito, Katsuhiro, Kanno, Toru, Okada, Takashi, Higashi, Yoshihito, Yamada, Hitoshi
Format: Article en ligne
Langue:Japanese
Publié: 2020
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:Case Reports Journal Article Bone Density Conservation Agents Diphosphonates Denosumab 4EQZ6YO2HI